Direct Cost Analysis of Hypertension in National Health Insurance Participants for the Advanced Level Healthcare in Indonesia : Analysis of BPJS Kesehatan Sample Data 2023

Akhmal Raziq Kharazi; Bambang Budi Raharjo

doi:10.55606/ijhs.v5i2.4992

Authors

Akhmal Raziq Kharazi Universitas Negeri Semarang
Bambang Budi Raharjo Universitas Negeri Semarang

DOI:

https://doi.org/10.55606/ijhs.v5i2.4992

Keywords:

BPJS Kesehatan, Direct Cost, Hypertension, Indonesia, National Health Insurance

Abstract

In 2023, WHO states one-third of individuals aged 30-79 have hypertension, only 42% receive treatment, and few of just 20% that receive it are controlled. Indonesia’s 2020-2022 Health Profile shows an annual increase of catastrophic disease burdened by the National Health Insurance (NHI), particularly for outpatient and inpatient advanced-level care. NHI’s Statistics of 2020-2021 reports increased utilization of healthcare services for hypertension-related visits from 2020 to 2021. This condition may cause an increase of economic burden to the healthcare system and pose financial risk for its participants. This study examines factors influencing the direct costs of hypertension-related visits among NHI participants at an advanced level. This study uses an analytical observational quantitative approach with a cohort design, utilizing the 2023 BPJS Kesehatan Sample Data. The total sampling method resulted in a total of 26.776 participants and 102.748 visits that were analyzed, with weighted results representing 2.207.606 participants and 8.583.700 visits. Data analysis included univariate, bivariate (simple logistic regression), and multivariate (multiple logistic regression) methods. Significant factors (p-value<0.05) affecting outpatient costs include age, regional type, administrative status, health facility ownership, and health facility type. Inpatient costs are influenced (p-value<0,05) by gender, regional type, class entitlement, health facility ownership, health facility type, comorbidities, length of stay, and severity. The study recommends evaluating advanced level healthcare tariff policies to minimize economic disparities in healthcare access across Indonesia.

Downloads

Download data is not yet available.

References

A. B. Zawudie, T. D. Lemma, and D. W. Daka, “Cost of Hypertension Illness and Associated Factors Among Patients Attending Hospitals in Southwest Shewa Zone, Oromia Regional State, Ethiopia,” ClinicoEconomics Outcomes Res., vol. 12, pp. 201–211, 2020. doi: 10.2147/CEOR.S241591.

A. Biswas, R. K. Singh, and S. K. Singh, “Medical and Non-Medical Cost of Hypertension and Heart Diseases in India,” Cogent Soc. Sci., vol. 2, no. 1, p. 1250616, 2016.

A. C. Esposito et al., “Do You Get What You Pay For? The Relationship of Price and Quality in Hospital Provided Procedures,” J. Surg. Res., vol. 278, pp. 140–148, 2022.

A. D. Laksono and C. Sandra, “Analisis Ekologi Persalinan di Fasilitas Pelayanan Kesehatan di Indonesia,” Bull. Penelit. Sist. Kesehat., vol. 23, no. 1, pp. 1–9, 2020.

A. F. Nilansari, N. M. Yasin, and D. A. Puspandari, “Analisis Tarif INA-CBGs Pasien Hipertensi Rawat Inap di Rumah Sakit Umum Daerah Panembahan Senopati,” Indones. J. Clin. Pharm., vol. 10, no. 1, pp. 22–29, 2021.

A. M. Iqbal and S. F. Jamal, "Essential Hypertension," NCBI Bookshelf, Jul. 20, 2023. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK539859/ [Accessed: Nov. 19, 2024].

A. P. I. Sinaga, “Korelasi Disparitas Ketersediaan Tenaga Medis Gigi Antardaerah terhadap Pemanfaatan Layanan Gigi dan Mulut di Indonesia,” J. Manaj. Pelayanan Kesehat., vol. 25, no. 3, pp. 108–115, 2022.

B. Nugroho and A. C. Sjaaf, “The Impact of Accreditation on the Quality of Hospital Service,” in Proc. Int. Conf. Public Health, vol. 4, no. 2, pp. 279–286, 2019.

BPJS Kesehatan and USAID, Buku Statistik JKN 2016–2021. Jakarta: BPJS Kesehatan, 2022.

C. Franco et al., “Essential Hypertension and Oxidative Stress: Novel Future Perspectives,” Int. J. Mol. Sci., vol. 23, no. 22, p. 14489, 2022. doi: 10.3390/ijms232214489.

C. Jo, "Cost-of-illness studies: concepts, scopes, and methods," Clinical and Molecular Hepatology, vol. 20, no. 4, p. 327, 2014. doi: 10.3350/cmh.2014.20.4.327.

C. N. Kohli-Lynch, A. Erzse, B. L. Rayner, and K. J. Hofman, “Hypertension in The South African Public Healthcare System: A Cost-of-Illness and Burden of Disease Study,” BMJ Open, vol. 12, no. 2, p. e055621, 2022.

CDC Polaris, “Cost of Illness,” Sep. 18, 2024. [Online]. Available: https://www.cdc.gov/polaris/php/economics/cost-illness.html. [Accessed: Dec. 1, 2024].

Centers for Disease Control and Prevention (CDC), "About High Blood Pressure," May 15, 2024. [Online]. Available: https://www.cdc.gov/high-blood-pressure/about/index.html [Accessed: Dec. 1, 2024].

D. G. Harrison, T. M. Coffman, and C. S. Wilcox, "Pathophysiology of Hypertension: The Mosaic Theory and Beyond," Circulation Research, vol. 128, no. 7, pp. 847–863, 2021. doi: 10.1161/CIRCRESAHA.121.318082.

D. Williams Jr. and M. Holmes, “Rural health care costs: are they higher and why might they differ from urban health care costs?,” N. C. Med. J., vol. 79, no. 1, pp. 51–55, 2018.

E. Adane, A. Atnafu, and A. Y. Aschalew, “The Cost of Illness of Hypertension and Associated Factors at the University of Gondar Comprehensive Specialized Hospital Northwest Ethiopia, 2018,” ClinicoEconomics Outcomes Res., vol. 12, pp. 133–140, 2020. doi: 10.2147/CEOR.S234674.

F. A. Sloan, G. A. Picone, D. H. Taylor Jr., and S. Y. Chou, “Hospital Ownership and Cost and Quality of Care: Is There a Dime’s Worth Of Difference?,” J. Health Econ., vol. 20, no. 1, pp. 1–21, 2001.

F. Baroroh and R. Maghfiroh, “Direct Medical Cost and Length of Stay of Hypertension Patients at Private Hospital in Yogyakarta,” J. Farm. Sains Praktis, pp. 27–33, 2023.

F. Longo, L. Siciliani, and A. Street, “Are Cost Differences Between Specialist and General Hospitals Compensated by The Prospective Payment System?,” Eur. J. Health Econ., vol. 20, pp. 7–26, 2019.

F. Yuliastuti, W. S. Hapsari, N. D. Kartikawati, and R. K. Mahato, “Cost Of Illness in Diabetic Patients with Hypertension in Inpatients at Sleman Regional Hospital,” J. Health Econ. Policy Res. (JHEPR), vol. 2, no. 2, 2024.

G. A. Nichols, E. L. Amitay, S. Chatterjee, and D. Steubl, “Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases,” Kidney360, vol. 4, no. 10, pp. 1382–1388, 2023. doi: 10.34067/KID.0000000000000212.

H. Maryani, L. Kristiana, A. Paramita, and N. Izza, “Disparitas Pembangunan Kesehatan di Indonesia Berdasarkan Indikator Keluarga Sehat Menggunakan Analisis Cluster,” Bull. Penelit. Sist. Kesehat., vol. 23, no. 1, pp. 18–27, 2020.

J. Geyman, “Investor-Owned Health Care: The Hidden Blight on America’s ‘System’,” Int. J. Health Serv., vol. 51, no. 4, pp. 494–500, 2021.

Kementerian Kesehatan RI, "Hipertensi Penyakit Paling Banyak Diidap Masyarakat," May 17, 2019. [Online]. Available: https://sehatnegeriku.kemkes.go.id/baca/umum/20190517/5130282/hipertensi-penyakit-paling-banyak-diidap-masyarakat/ [Accessed: Aug. 28, 2024].

Kementerian Kesehatan RI, "Klasifikasi Hipertensi," 2023. [Online]. Available: https://p2ptm.kemkes.go.id/infographic-p2ptm/hipertensi-penyakit-jantung-dan-pembuluh-darah/page/28/klasifikasi-hipertensi [Accessed: Aug. 28, 2023].

Kementerian Kesehatan RI, Peraturan Menteri Kesehatan Nomor 28 Tahun 2014 tentang Pedoman Pelaksanaan Jaminan Kesehatan Nasional. Jakarta: Kementerian Kesehatan RI, 2014.

Kementerian Kesehatan RI, Peraturan Menteri Kesehatan Nomor 3 Tahun 2023 Tentang Standar Tarif Pelayanan Kesehatan dalam Penyelenggaraan Program Jaminan Kesehatan. Jakarta: Kementerian Kesehatan RI, 2023.

Kementerian Kesehatan RI, Peraturan Menteri Kesehatan Nomor 76 Tahun 2016 tentang Pedoman Indonesian Case Base Groups (INA-CBG) dalam Pelaksanaan Jaminan Kesehatan Nasional. Jakarta: Kementerian Kesehatan RI, 2016.

Kementerian Kesehatan RI, Profil Kesehatan Indonesia Tahun 2020. Jakarta: Kementerian Kesehatan RI, 2021.

Kementerian Kesehatan RI, Profil Kesehatan Indonesia Tahun 2021. Jakarta: Kementerian Kesehatan RI, 2022.

Kementerian Kesehatan RI, Profil Kesehatan Indonesia Tahun 2022. Jakarta: Kementerian Kesehatan RI, 2023.

M. Johar et al., “Inequality in Access to Health Care, Health Insurance and the Role of Supply Factors,” Soc. Sci. Med., 2018. doi: 10.1016/j.socscimed.2018.07.044.

M. Mleşnişe and I. S. Bocşan, “Comparison Between a Multi-Pavilion Hospital and a Single Pavilion Hospital,” Clujul Med., vol. 89, no. 3, p. 402, 2016.

M. S. Pavel, S. Chakrabarty, and J. Gow, “Cost of Illness for Outpatients Attending Public and Private Hospitals in Bangladesh,” Int. J. Equity Health, vol. 15, pp. 1–12, 2016.

M. Ying, S. Wang, C. Bai, and Y. Li, “Rural-urban differences in health outcomes, healthcare use, and expenditures among older adults under universal health insurance in China,” PLoS ONE, vol. 15, no. 10, p. e0240194, 2020. doi: 10.1371/journal.pone.0240194.

N. Nurmainah, A. Fudholi, and I. Dwiprahasto, “Kepatuhan Penggunaan Antihipertensi Sebagai Prediktor Laju Kejadian dan Biaya Rawat Inap,” J. Manaj. Pelayanan Farmasi, vol. 4, no. 4, pp. 200–206, 2014.

Pemerintah Indonesia, Undang-Undang Nomor 17 Tahun 2023 Tentang Kesehatan. Jakarta: Pemerintah Indonesia, 2023.

Pemerintah Indonesia, Undang-Undang Nomor 24 Tahun 2011 Tentang Badan Penyelenggara Jaminan Sosial. Jakarta: Pemerintah Indonesia, 2011.

Pemerintah Indonesia, Undang-Undang Nomor 40 Tahun 2004 Tentang Sistem Jaminan Sosial Nasional. Jakarta: Pemerintah Indonesia, 2004.

S. Garg, N. Tripathi, A. Ranjan, and K. K. Bebarta, “Comparing the Average Cost of Outpatient Care of Public and For-Profit Private Providers in India,” BMC Health Serv. Res., vol. 21, no. 1, p. 838, 2021.

S. Huang, S. Zhang, J. Wang, G. Hou, and S. Xu, “Correlation Between Serum Cystatin C Level and Retinal Blood Flow in Patients with Essential Hypertension,” Ophthalmic Res., vol. 65, no. 3, pp. 335–341, 2022. doi: 10.1159/000522219.

S. S. Kar, V. K. Kalidoss, U. Vasudevan, and S. Goenka, “Cost of Care for Hypertension in a Selected Health Center of Urban Puducherry: An Exploratory Cost-of-Illness Study,” Int. J. Noncommun. Dis., vol. 3, no. 3, pp. 98–103, 2018.

S. Woolhandler and D. U. Himmelstein, “Costs of Care and Administration at For-Profit and Other Hospitals in The United States,” N. Engl. J. Med., vol. 336, no. 11, pp. 769–774, 1997. doi: 10.1056/NEJM199703133361106.

T. Unger, C. Borghi, F. Charchar, N. A. Khan, N. R. Poulter et al., "2020 International Society of Hypertension Global Hypertension Practice Guidelines," Hypertension, vol. 75, no. 6, pp. 1334–1357, 2020. doi: 10.1161/HYPERTENSIONAHA.120.15026.

W. C. Stewart, J. A. Stewart, Q. J. Nasser, and M. A. Mychaskiw, “Cost-effectiveness of treating ocular hypertension,” Ophthalmology, vol. 115, no. 1, pp. 94–98, 2008. doi: 10.1016/j.ophtha.2007.01.040.

World Health Organization, "Hypertension," Mar. 16, 2023. [Online]. Available: https://www.who.int/health-topics/hypertension#tab=tab_1 [Accessed: Aug. 28, 2024].

World Health Organization, Global Report on Hypertension: the race against a silent killer. Geneva: World Health Organization, 2023.

World Health Organization, Health Care Accreditation and Quality of Care: Exploring The Role of Accreditation and External Evaluation of Health Care Facilities and Organizations, Geneva: WHO, 2022.

World Health Organization, International Statistical Classification of Diseases and Related Health Problems 10th Revision. Geneva: World Health Organization, 2019.

X. Chen et al., “Differences in Rural and Urban Health Information Access and Use,” J. Rural Health, vol. 35, no. 3, pp. 405–417, 2019. doi: 10.1111/jrh.12335.

Y. A. Halasa, W. Zeng, E. Chappy, and D. S. Shepard, “Value and impact of international hospital accreditation: a case study from Jordan,” East. Mediterr. Health J., vol. 21, no. 2, pp. 90–99, 2015. doi: 10.26719/2015.21.90.

Y. M. Bambungan, R. A. Oetari, and S. Satibi, “Analisis Biaya Pengobatan Hipertensi pada Pasien Rawat Inap di RSUD Sorong,” 2-TRIK: Tunas-Tunas Riset Kesehatan, vol. 7, no. 2, pp. 72–76, 2017.

Y. Samuela, Cost of Illness Peserta JKN Penderita Penyakit Jantung Iskemik di Indonesia: Analisis Data Sampel BPJS Kesehatan Tahun 2022, Undergraduate Thesis, Faculty of Public Health, Universitas Indonesia, Depok, 2024.

Z. Mazidah, N. M. Yasin, and S. A. Kristina, “Analisis Biaya Penyakit Stroke Pasien Jaminan Kesehatan Nasional di RSUD Blambangan Banyuwangi,” J. Manaj. Pelayanan Farmasi, vol. 9, no. 2, pp. 76–87, 2019.